Promoter Hypermethylation of the EMP3 Gene in a Series of 229 Human Gliomas
Figure 5
Univariate analysis for EMP3 promoter hypermethylation and total 1p/19q codeletion in oligodendroglial tumors. Kaplan-Meier survival analysis for (a) EMP3 hypermethylation versus patient overall survival (OS) in WHO grade II-III tumors, (b) EMP3 hypermethylation versus OS in WHO grade III tumors, (c), total 1p/19q codeletion versus OS in WHO grade II-III tumors, (d) total 1p/19q codeletion versus OS in WHO grade III tumors. Censored cases between EMP3 unmethylated and methylated patients are 7 and 21, respectively. Censored cases between patients with total 1p/19q codeletion and patients without total 1p/19q codeletion are 16 and 12, respectively.
